Fusion Pharmaceuticals Inc.

Ownership Transactions Reported by 17 Insiders

Location
270 Longwood Road South, Hamilton, Ontario, Canada

There are no Buy or Sell transactions made by insiders since 10/5/2023

Fusion Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Valliant Chief Executive Officer, Director $457K Jun 4, 2024
Mohit Rawat President & CBO $224K Jun 4, 2024
Steven Gannon Director $134K Jun 4, 2024
Chau Q. Khuong Director $100K Jun 14, 2023
James O'Leary Chief Medical Officer $4.81K Feb 1, 2022
John J. Crowley Chief Financial Officer $0 Jun 4, 2024
Christopher Leamon Chief Scientific Officer $0 Jun 4, 2024
Eric Burak Chief Technology Officer $0 Jun 4, 2024
Dmitri Bobilev Chief Medical Officer $0 Jun 4, 2024
Heather Preston Director Jun 14, 2023
Pablo J. Cagnoni Director Jun 4, 2024
Jeremy Bender Director Jun 4, 2024
Donald A. Bergstrom Director Jun 4, 2024
Barbara Gayle Duncan Director Jun 4, 2024
David D. Meek Director Jun 4, 2024
Philina Lee Director Jun 4, 2024
Teresa Bitetti Director Jun 4, 2024

Recent Insider Transactions by Companies or Individuals for Fusion Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.